Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Balaji Amines's Other Operating Expense for the
three
months ended in Mar. 2026 was ₹935 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4,141 Mil.
Balaji Amines's quarterly Other Operating Expense
declined
from Sep. 2025 (₹1,100 Mil) to Dec. 2025 (₹1,050 Mil) and
declined
from Dec. 2025 (₹1,050 Mil) to Mar. 2026 (₹935 Mil).
Balaji Amines's annual Other Operating Expense
declined
from Mar. 2024 (₹3,144 Mil) to Mar. 2025 (₹3,101 Mil) and
declined
from Mar. 2025 (₹3,101 Mil) to Mar. 2026 (₹2,815 Mil).
Balaji Amines Other Operating Expense Related Terms
Balaji Amines Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Balaji Amines's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,141 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹4,141 Mil mean?
Balaji Amines (NSE:BALAMINES) has a Other Operating Expense of ₹4,141 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Balaji Amines and its competitors.
Is Balaji Amines' Other Operating Expense too high?
Balaji Amines' current Other Operating Expense is ₹4,141 Mil. Overall, Balaji Amines has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Balaji Amines' Other Operating Expense compare to LIN and SHW?
Balaji Amines' Other Operating Expense of ₹4,141 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Chemicals company?
A good Other Operating Expense depends on the Chemicals industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Balaji Amines and its competitors. Balaji Amines's current Other Operating Expense is ₹4,141 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balaji Amines stock overvalued right now?
Based on GuruFocus' analysis, Balaji Amines (NSE:BALAMINES) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,668.78, compared to a current price of ₹2,289.10 — trading 37.2% above its estimated fair value. The current Other Operating Expense is ₹4,141 Mil. Balaji Amines' overall GF Score™ is 78/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Balaji Amines (NSE:BALAMINES), the current Other Operating Expense is ₹4,141 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balaji Amines (NSE:BALAMINES) Overvalued in 2026?
Based on GuruFocus' analysis, Balaji Amines stock appears to be overvalued.
The current stock price of ₹2,289.10 is trading 37.2% above its estimated GF Value™ of ₹1,668.78.
GuruFocus considers Balaji Amines to be Significantly Overvalued.
Key valuation signals for NSE:BALAMINES:
Other Operating Expense: ₹4,141 Mil
GF Value™: ₹1,668.78 vs. price of ₹2,289.10 (37.2% above fair value)
No single metric tells the full story. See the NSE:BALAMINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balaji Amines Ltd is engaged in the manufacture and sale of aliphatic amines, speciality chemicals, and their derivatives. The Company's manufacturing facilities operate through Distributed Control Systems (DCS), indigenous process technologies, and a Zero Liquid Discharge (ZLD) framework. The business operates through the Chemicals and Hotel segments, with the Chemicals segment generating maximum revenue. Its products include amines such as Mono Methyl Amine (MMA), Di-Methyl Amine (DMA) and others; speciality chemicals such as Morpholine, Acetonitrile (ACN), and others; and amine derivatives such as Mono-Methyl Amine Hydrochloride (MMA HCL), Di-Methyl Amine Hydrochloride (DMA HCL) and others. Geographically, the Company generates maximum revenue from India.
78GF Score
Get the complete analysis for NSE:BALAMINES
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BALAMINES has been successfully added to your 
